|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Chronic Hepatitis B | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Hepatitis | |||||
| Hepatitis B | |||||
| Hepatitis B, Chronic | |||||
| Hepatitis, Chronic | |||||
| 3 | More general conditions related to this trial | ||||
| Digestive System Diseases | |||||
| DNA Virus Infections | |||||
| Hepadnaviridae Infections | |||||
| Hepatitis, Viral, Human | |||||
| Liver Diseases | |||||
| Virus Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| telbivudine | |||||
| 5 | Sponsors listed in this trial | ||||
| Novartis | |||||